PLANO, Texas -- (BUSINESS WIRE) -- VuCOMP, Inc. announced today that it has installed its advanced M-Vu computer-aided detection (CAD) system at The Rose, the leading nonprofit breast health organization in southeast Texas. VuCOMP’s CAD is designed to provide an unprecedented level of performance to help radiologists find breast cancer earlier. This technology helps The Rose fulfill its promise to deliver state-of-the-art health care to women regardless of their ability to pay.
VuCOMP’s M-Vu system analyzes mammographic images and marks suspicious areas using sophisticated mathematical algorithms.
“I’ve had experience with several CAD systems, and VuCOMP’s product is proving to be superior,” said Ward Parsons, MD, RT, RDMS, lead interpreting physician at The Rose. “Additionally, VuCOMP has shown itself to be invested in continual improvement, and has been receptive to suggestions from radiologists, which means better outcomes all around.”
According to The Rose co-founder and CEO, Dorothy Weston Gibbons, “Our mission is to remove the barriers to cancer screening and provide quality health care for all women in the region. Our insistence on quality care includes physician and staff expertise and experience along with compassionate interactions with patients as well as the use of advanced technology. VuCOMP is a critical component that allows us to serve more women more quickly—and we can hopefully save more lives.”
The VuCOMP system received FDA approval to work with film mammography in January 2012, and a supplemental approval for digital mammography in October 2012. While CAD systems have been used in clinical practice since the mid-1990s, recent FDA guidelines have significantly raised the bar for CAD performance requirements, and now recommend comprehensive reader studies proving that radiologists are more effective when they use CAD. The VuCOMP system is the only FDA-approved mammography CAD product in the world that meets these recommendations.
Jeff Wehnes, President and CEO of VuCOMP, said, “With The Rose’s emphasis on quality and excellence in the services it provides to all women, we are pleased that our technology was selected for their digital mammography practice. VuCOMP and The Rose share the same goal: to detect breast cancer earlier, which can lead to earlier intervention and better outcomes.”
About The Rose
The Rose offers advanced breast cancer screening and diagnostic services including mammograms, ultrasounds, biopsies and access to treatment to more than 33,000 women annually. The organization is composed of board certified radiologists, specialized technical staff, two mammography and diagnostic imaging centers, and a fleet of mobile mammography vans. To meet the needs of insured and uninsured women in the Houston area and surrounding counties, The Rose depends on revenue from paying customers, grants, and donations. Since its launch in 1987, The Rose has served more than 385,000 patients and is now the leading nonprofit breast health care organization in southeast Texas.
About VuCOMP, Inc.
VuCOMP, Inc. designs, develops, and markets software systems for automatic analysis of medical images. The company maintains a large investment in ongoing research and development to continually introduce new products and enhancements that help radiologists find disease earlier and save lives. For more information, please visit www.vucomp.com.